Product
[225]-FPI-2059
1 clinical trial
7 indications
Indication
Pancreatic Ductal AdenocarcinomaIndication
Squamous Cell Carcinoma of Head and NeckIndication
Colorectal CancerIndication
Stomach CancerIndication
Ewing SarcomaIndication
NTSR1-expressing solid tumorsClinical trial
A Phase 1 Study of [225Ac]-FPI-2059 in Adult Participants With NTSR1-Expressing Advanced, Metastatic and/or Recurrent Solid TumoursStatus: Recruiting, Estimated PCD: 2025-06-01